Gempharmatech Co. Ltd. A (688046) — Capital Reinvestment Ratio
Latest as of December 2024:
1.26x
Gempharmatech Co. Ltd. A (688046) has a Capital Reinvestment Ratio of 1.26x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥90.31 Million) in capital expenditures (CN¥113.68 Million). See free cash flow generation of Gempharmatech Co. Ltd. A to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.26x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥90.31 Million
CNY
Capital Expenditures
CN¥113.68 Million
CNY
Data as of
Dec 2024
Most recent filing
Gempharmatech Co. Ltd. A Capital Reinvestment Ratio (2019–2024)
This chart tracks Gempharmatech Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Gempharmatech Co. Ltd. A (2019–2024)
Year-by-year Capital Reinvestment Ratio for Gempharmatech Co. Ltd. A from 2019 to 2024. For live market cap and broader valuation context, see 688046 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.26x | CN¥90.31 Million | CN¥113.68 Million | ▼ -28.7% |
| 2023 | 1.77x | CN¥116.57 Million | CN¥205.90 Million | ▼ -1.6% |
| 2022 | 1.80x | CN¥105.98 Million | CN¥190.31 Million | ▲ +128.4% |
| 2021 | 0.79x | CN¥113.31 Million | CN¥89.07 Million | ▼ -38.9% |
| 2020 | 1.29x | CN¥129.79 Million | CN¥167.07 Million | ▲ +83.6% |
| 2019 | 0.70x | CN¥65.12 Million | CN¥45.66 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow